On May 20, Moderna rose 5.07% in regular trading, trading at $47.975 USD/share, with trading volume of approximately $51.74 million.
Within the Biotechnology sector where Moderna belongs, among individual stocks, Immunovant up 31.1%, Roivant Sciences up 14.91%, Regeneron Pharmaceuticals up 2.09%, Amgen down 0.29%, AbbVie down 0.4%.
Moderna is a leader in the field of messenger RNA (mRNA) medicine. Its mRNA platform has enabled the development of therapeutics and vaccines across infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments